Cargando…
Signalling Pathways Implicated in Alzheimer′s Disease Neurodegeneration in Individuals with and without Down Syndrome
Down syndrome (DS), the most common cause of intellectual disability of genetic origin, is characterized by alterations in central nervous system morphology and function that appear from early prenatal stages. However, by the fourth decade of life, all individuals with DS develop neuropathology iden...
Autores principales: | Martínez-Cué, Carmen, Rueda, Noemí |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555886/ https://www.ncbi.nlm.nih.gov/pubmed/32962300 http://dx.doi.org/10.3390/ijms21186906 |
Ejemplares similares
-
Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials
por: Rueda Revilla, Noemí, et al.
Publicado: (2020) -
Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer’s Disease
por: Vidal, Verónica, et al.
Publicado: (2021) -
Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
por: Rueda, Noemí, et al.
Publicado: (2012) -
Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome
por: García-Cerro, Susana, et al.
Publicado: (2014) -
Oxidative-Stress-Associated Proteostasis Disturbances and Increased DNA Damage in the Hippocampal Granule Cells of the Ts65Dn Model of Down Syndrome
por: Puente-Bedia, Alba, et al.
Publicado: (2022)